| __timestamp | ImmunityBio, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 15746000 |
| Thursday, January 1, 2015 | 226206000 | 13392000 |
| Friday, January 1, 2016 | 94391000 | 9290000 |
| Sunday, January 1, 2017 | 53821000 | 7672000 |
| Monday, January 1, 2018 | 35463000 | 15293000 |
| Tuesday, January 1, 2019 | 46456000 | 22648000 |
| Wednesday, January 1, 2020 | 71318000 | 21864000 |
| Friday, January 1, 2021 | 135256000 | 37318000 |
| Saturday, January 1, 2022 | 102708000 | 48130000 |
| Sunday, January 1, 2023 | 129620000 | 108146000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, ImmunityBio, Inc. and Madrigal Pharmaceuticals, Inc. have showcased contrasting strategies in this domain. ImmunityBio's SG&A expenses peaked in 2015, reaching a staggering 226 million, while Madrigal's highest was in 2023, at 108 million. Despite ImmunityBio's higher expenses, their trend shows a more volatile pattern, with a significant drop to 35 million in 2018. In contrast, Madrigal's expenses have steadily increased, reflecting a more consistent growth strategy. By 2023, Madrigal's SG&A expenses were nearly 48% of ImmunityBio's, highlighting their efficient cost management. This analysis underscores the importance of strategic financial planning in sustaining growth and competitiveness in the biotech industry.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.